CLINIAL CO., LTD. (CEO: Takaaki Mizuno) has been selected for the United Kingdom course of the fiscal 2026 X-HUB TOKYO GLOBAL STARTUP ACCELERATOR OUTBOUND PROGRAM, organized by the Tokyo Metropolitan Government and operated by the Japan External Trade Organization (JETRO). With JETRO’s support, we have begun business development and market expansion in the United Kingdom.
In early 2027, we plan to visit Cambridge and London to share the value of Japan’s healthcare and clinical development environment with biotech and pharmaceutical companies, contract research organizations (CROs), and investors. We will build connections with overseas companies considering drug development in Japan and explore collaborations that help bring new medicines to patients in Japan.
For details, please see the press release (in Japanese).
(Reference)